BeiGene Other Operating Expenses from 2010 to 2024
| BGNE Stock | USD 144.12 5.13 3.69% |
Other Operating Expenses | First Reported 2013-12-31 | Previous Quarter 914 M | Current Value 1 B | Quarterly Volatility 330.2 M |
Check BeiGene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BeiGene main balance sheet or income statement drivers, such as Depreciation And Amortization of 92.1 M, Interest Expense of 39.2 M or Selling General Administrative of 1.5 B, as well as many exotic indicators such as Price To Sales Ratio of 7.27, Dividend Yield of 0.0 or PTB Ratio of 4.02. BeiGene financial statements analysis is a perfect complement when working with BeiGene Valuation or Volatility modules.
BeiGene | Other Operating Expenses |
Latest BeiGene's Other Operating Expenses Growth Pattern
Below is the plot of the Other Operating Expenses of BeiGene over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of BeiGene. It is also known as BeiGene overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. BeiGene's Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BeiGene's overall financial position and show how it may be relating to other accounts over time.
| Other Operating Expenses | 10 Years Trend |
|
Other Operating Expenses |
| Timeline |
BeiGene Other Operating Expenses Regression Statistics
| Arithmetic Mean | 1,214,090,583 | |
| Geometric Mean | 259,901,670 | |
| Coefficient Of Variation | 120.60 | |
| Mean Deviation | 1,254,276,700 | |
| Median | 336,844,000 | |
| Standard Deviation | 1,464,179,073 | |
| Sample Variance | 2143820.4T | |
| Range | 3.8B | |
| R-Value | 0.92 | |
| Mean Square Error | 355707.9T | |
| R-Squared | 0.85 | |
| Slope | 301,124,572 | |
| Total Sum of Squares | 30013485T |
BeiGene Other Operating Expenses History
About BeiGene Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include BeiGene income statement, its balance sheet, and the statement of cash flows. BeiGene investors use historical funamental indicators, such as BeiGene's Other Operating Expenses, to determine how well the company is positioned to perform in the future. Although BeiGene investors may use each financial statement separately, they are all related. The changes in BeiGene's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on BeiGene's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on BeiGene Financial Statements. Understanding these patterns can help to make the right decision on long term investment in BeiGene. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Other Operating Expenses | 3.7 B | 3.8 B |
Pair Trading with BeiGene
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BeiGene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BeiGene will appreciate offsetting losses from the drop in the long position's value.Moving against BeiGene Stock
| 0.64 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.54 | ELYM | Eliem Therapeutics | PairCorr |
| 0.47 | CGC | Canopy Growth Corp Trending | PairCorr |
The ability to find closely correlated positions to BeiGene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BeiGene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BeiGene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BeiGene to buy it.
The correlation of BeiGene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BeiGene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BeiGene moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BeiGene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of BeiGene Correlation against competitors. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for BeiGene Stock analysis
When running BeiGene's price analysis, check to measure BeiGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeiGene is operating at the current time. Most of BeiGene's value examination focuses on studying past and present price action to predict the probability of BeiGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeiGene's price. Additionally, you may evaluate how the addition of BeiGene to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is BeiGene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeiGene. If investors know BeiGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeiGene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.45) | Revenue Per Share 23.554 | Quarterly Revenue Growth 0.669 | Return On Assets (0.12) | Return On Equity (0.22) |
The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own opinion of BeiGene's value that differs from its market value or its book value, called intrinsic value, which is BeiGene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeiGene's market value can be influenced by many factors that don't directly affect BeiGene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.